NCT00002050View on ClinicalTrials.gov

A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients

NACompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Thymopentin

Trial Locations (1)

088010999

Immunobiology Research Institute, Annandale

Sponsors
All Listed Sponsors
lead

Immunobiology Research Institute

INDUSTRY

NCT00002050 - A Study of Thymopentin Effects on HIV-1 Infectivity of Blood Mononuclear Cells and Semen in HIV Infected Patients | Biotech Hunter | Biotech Hunter